Antihypertensive Drug Prescribing Pattern at Pharmacy X Yogyakarta

Shintia Claudia Atiameru; Didiek Hardiyanto Soegiantoro; Sarah Puspita Atmaja

Authors

Shintia Claudia Atiameru Fakultas Farmasi, Universitas Kristen Immanuel, Yogyakarta, Indonesia
Didiek Hardiyanto Soegiantoro Fakultas Farmasi, Universitas Kristen Immanuel, Yogyakarta, Indonesia
Sarah Puspita Atmaja Fakultas Farmasi, Universitas Kristen Immanuel, Yogyakarta, Indonesia

Keywords:

Prescribing Pattern, Antihypertensive, Gender Characteristics, Antihypertensive Pharmacotherapy Class, Pharmacy

Abstract

Hypertensive patients who have seen a doctor at primary or advanced health facilities generally get a doctor's prescription. On the antihypertensive drug prescription sheet, information can be obtained about the pattern of prescribing antihypertensive drugs such as the classification of antihypertensive drugs used for patient treatment and gender characteristics of hypertensive patients. This study aims to describe the characteristics of hypertensive patients and the types of antihypertensive drugs prescribed by doctors and purchased at Pharmacy X Yogyakarta. The research method used was a retrospective quantitative descriptive study using a sample of the entire population of prescriptions containing antihypertensive drugs during January to June 2023. The results of the study found that the number of prescriptions containing antihypertensive drugs at Pharmacy X Yogyakarta fluctuated between 3 to 10, with the gender characteristics of patients balanced between men and women. The types of antihypertensive drugs that patients buy every month with a doctor's prescription are the most cardioselective beta blockers, ARBs, and CCBs of dihydropyridine

References

S. E. Kjeldsen, “Hypertension and cardiovascular risk: General aspects,” Pharmacol. Res., vol. 129, pp. 95–99, 2018.

R. Kreutz et al., “Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic,” J. Hypertens., vol. 39, no. 6, pp. 1077–1089, 2021.

R. Gupta, K. Gaur, and C. V. S. Ram, “Emerging trends in hypertension epidemiology in India,” J. Hum. Hypertens., vol. 33, no. 8, pp. 575–587, 2019.

P. Patel et al., “Improved blood pressure control to reduce cardiovascular disease morbidity and mortality: the standardized hypertension treatment and prevention project,” J. Clin. Hypertens., vol. 18, no. 12, pp. 1284–1294, 2016.

H.-Y. Lee et al., “2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension,” Clin. Hypertens., vol. 25, pp. 1–24, 2019.

N. R. Poulter et al., “Medication adherence in hypertension,” J. Hypertens., vol. 38, no. 4, pp. 579–587, 2020.

N. K. Choudhry et al., “Medication adherence and blood pressure control: a scientific statement from the American Heart Association,” Hypertension, vol. 79, no. 1, pp. e1–e14, 2022.

H. Lee et al., “Adherence to antihypertensive medication and incident cardiovascular events in young adults with hypertension,” Hypertension, vol. 77, no. 4, pp. 1341–1349, 2021.

O. Adejumo et al., “Assessment of hypertension service availability in some primary health centres in Nigeria: a mixed-methods study,” BMJ Open, vol. 13, no. 8, p. e073833, 2023.

S. G. Paradkar and S. R. Sinha, “Drug utilization among hypertensive patients in the outpatient department of medicine in a tertiary care hospital: A cross-sectional study,” Clin. Exp. Hypertens., vol. 40, no. 2, pp. 150–154, 2018.

M. Al-Ababneh, “Linking ontology, epistemology and research methodology,” Sci. Philos., vol. 8, no. 1, pp. 75–91, 2020.

M. H. Aji, M. Z. Hilmi, and M. T. Rahman, “The Living Qur’an as a Research Object and Methodology in the Qur’anic Studies,” J. Iman Dan Spiritualitas, vol. 1, no. 1, pp. 78–84, 2021.

H. Abbas et al., “Factors associated with antihypertensive medication Non-Adherence: a cross-sectional study among Lebanese hypertensive adults,” Patient Prefer. Adherence, pp. 663–673, 2020.

A. Prihayati, “Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies under the National Health Insurance Program,” in The International Conference on Public Health Proceeding, 2023, vol. 4, no. 02, pp. 263–269.

A. Khera et al., “Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology,” Am. J. Prev. Cardiol., vol. 1, p. 100009, 2020.